Quick Answer
Structure Therapeutics Inc. reported Stockholders Equity of $1.52 billion for fiscal year 2025.
Structure Therapeutics Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.52B | +75.3% |
| 2024 | $864.84M | +90.9% |
| 2023 | $452.97M | +493.4% |
| 2022 | -$115.14M | -77.9% |
| 2021 | -$64.73M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $770.02M | -14.1% | -0.3% |
| June 30, 2025 | $772.08M | -16.2% | -6.4% |
| March 31, 2025 | $824.64M | +91.9% | -4.6% |
| December 31, 2024 | $864.84M | +90.9% | -3.6% |
| September 30, 2024 | $896.80M | +364.8% | -2.6% |
| June 30, 2024 | $921.03M | +329.6% | +114.3% |
| March 31, 2024 | $429.82M | +81.9% | -5.1% |
| December 31, 2023 | $452.97M | +493.4% | +134.7% |
- Structure Therapeutics Inc. showed an increase of +75.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2021–2025 period, Structure Therapeutics Inc.’s stockholders equity has grown by 2442.4% (from -$64.73 million to $1.52 billion).
- The most recent figure is from Structure Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: